242 related articles for article (PubMed ID: 3001842)
21. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
22. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
Rodríguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
23. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
[TBL] [Abstract][Full Text] [Related]
24. Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands.
Dehaye JP; Christophe J; Ernst F; Poloczek P; Van Bogaert P
Arch Oral Biol; 1985; 30(11-12):827-32. PubMed ID: 2421696
[TBL] [Abstract][Full Text] [Related]
25. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
27. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
Westendorf JM; Schonbrunn A
Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
[TBL] [Abstract][Full Text] [Related]
28. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.
Robberecht P; Tatemoto K; Chatelain P; Waelbroeck M; Delhaye M; Taton G; De Neef P; Camus JC; Heuse D; Christophe J
Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
30. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
31. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
32. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
33. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
Shima K; Sakakibara H; Said SI
Regul Pept; 1996 Jul; 63(2-3):99-103. PubMed ID: 8837217
[TBL] [Abstract][Full Text] [Related]
34. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
35. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro.
Sawangjaroen K; Sernia C; Curlewis JD
J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin inhibits growth hormone-releasing factor-stimulated adenylate cyclase activity in GH, cells.
Reyl-Desmars F; Zeytin F
Biochem Biophys Res Commun; 1985 Mar; 127(3):986-91. PubMed ID: 2859018
[TBL] [Abstract][Full Text] [Related]
37. Binding sites for peptide-histidine-isoleucine (PHI) on rat insulinoma-derived RINm5F cells.
Göke R; Conlon JM
Mol Cell Endocrinol; 1988 Dec; 60(2-3):211-5. PubMed ID: 2850958
[TBL] [Abstract][Full Text] [Related]
38. Identification of a VIP-specific receptor in guinea pig tenia coli.
Teng BQ; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G718-25. PubMed ID: 11518684
[TBL] [Abstract][Full Text] [Related]
39. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
